6.5.2 Posterior pituitary hormones and antagonists

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

55 library items in 6.5.2 Posterior pituitary hormones and antagonists

Filter results by:

Date Published

NeLM Area

Results filtered by:

Category

6: Endocrine system (remove) , 6.5 Hypothalamic and pituitary hormones and anti-o (remove) , 6.5.2 Posterior pituitary hormones and antagonists (remove)

Sort by: Display summary:

Results 1 - 10 of 55

Result page:
Previous
|
1
2
3
4
5
6
|
Next

1.

Horizon scanning: Lucassin® (terlipressin) approved for hepatorenal syndrome in Australia

Source: BioSpace ,
Date published: 25/04/2012

Category:

6.5.2 Posterior pituitary hormones and antagonists | Liver disease | New drugs

NeLM Area:

News

Link
2.

MHRA Drug Safety Update: over-rapid increase in serum sodium and risk of serious neurological events with tolvaptan (Samsca®)

Source: MHRA Drug Safety Update,
Date published: 23/04/2012

Category:

6.5.2 Posterior pituitary hormones and antagonists | Adverse Drug Reactions | Drug Alerts | Endocrinology | Medicines and Healthcare products Regulatory Agency (MHRA)

NeLM Area:

Evidence > Medication Safety

Link
3.

Updated national IV monograph on Desmopressin

Source: Medusa,
Date published: 20/02/2012

Category:

6.5.2 Posterior pituitary hormones and antagonists | Drug Administration

NeLM Area:

News

Link- registration required
4.

NETAG issues final recommendation, following appeal, on the use of tolvaptan for hyopnatraemia due to SIADH

Source: NETAG ,
Date published: 14/10/2011

Category:

6.5.2 Posterior pituitary hormones and antagonists | Drug reviews | Endocrinology

NeLM Area:

Evidence > Drug Specific Reviews

Recommendation

Associated treatment protocol
5.

NETAG appraisal and recommendation: Tolvaptan (Samsca®) for the syndrome of inappropriate antidiuretic hormone secretion (SIADH)

Source: NETAG ,
Date published: 15/04/2011

Category:

6.5.2 Posterior pituitary hormones and antagonists | Drug reviews | Endocrinology

NeLM Area:

Evidence > Drug Specific Reviews

Appraisal report

Recommendations
6.

European CHMP informed of possible supply shortage of Thyrogen (thyrotropin alfa)

Source: European Medicines Agency (EMA),
Date published: 18/03/2011

Category:

6.5.2 Posterior pituitary hormones and antagonists | Cancer: other | Drug shortages | Endocrinology | European Agency for the Evaluation of Medicinal Products (EMEA) | Prescribing and supply of medicines

NeLM Area:

News

Press release
7.

Clinical Knowledge Summary: Bedwetting (enuresis)

Source: Clinical Knowledge Summaries (CKS),
Date published: 11/01/2011

Category:

6.5.2 Posterior pituitary hormones and antagonists | Clinical guidelines | Incontinence | Paediatrics

NeLM Area:

Evidence > Guidelines

Link
8.

Did the removal of the indication of nocturnal enuresis for intranasal desmopressin change prescribing practice?

Source: Pharmacoepidemiology and Drug Safety,
Date published: 23/12/2010

Category:

6.5.2 Posterior pituitary hormones and antagonists

NeLM Area:

Evidence > Medicines Management > References

Abstract link
9.

RCT: Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia

Source: J Urology,
Date published: 25/11/2010

Category:

6.5.2 Posterior pituitary hormones and antagonists | Benign prostatic hypertrophy | Incontinence

NeLM Area:

News

Abstract
10.

NICE Bites – November 2010; Nocturnal enuresis

Source: North West Medicines Information Centre,
Date published: 16/11/2010

Category:

4.3.1 Tricyclic and related antidepressant drugs | 6.5.2 Posterior pituitary hormones and antagonists | Adolescents (11-18 years) | Children (2-11 years) | Clinical guidelines | Drugs in paediatrics | Incontinence | National Institute of Clinical Excellence (NICE)

NeLM Area:

Health In Focus

NICEBitesNovember2010.pdf

Results 1 - 10 of 55

Result page:
Previous
|
1
2
3
4
5
6
|
Next